Tag Archive for ‘ductal carcinoma in situ’
Because many cases of ductal carcinoma in situ (DCIS) may remain stable without excision, more clinical trials are exploring the role of active surveillance in DCIS management.
The COMET Trial—a prospective randomized study aimed at assessing the risks and benefits associated with active surveillance versus guideline concordant care for patients with low-risk ductal carcinoma in situ—is the focus of this month’s column.
In a typical breast surgery practice, nearly one-fifth of new patients present with ductal carcinoma in situ (DCIS), usually detected on mammography as an incidental finding. Most of these women are otherwise healthy, take care of themselves, have had a mammogram as part of their routine health maintenance, and are now grappling with a “cancer” […]